Financhill
Back

Adagene Quote, Financials, Valuation and Earnings

Adagene Price Quote

$1.96
-0.08 (-2.49%)
(Updated: December 21, 2024 at 5:13 AM ET)

Adagene Key Stats

Sell
33
Adagene (ADAG) is a Sell

Day range:
$1.89 - $2.07
52-week range:
$1.60 - $4.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.96
P/B ratio:
1.6%

Volume:
36.8K
Avg. volume:
85.5K
1-year change:
13.33%
Market cap:
$90.3M
Revenue:
$18.1M
EPS:
$-0.73

How Much Does Adagene Make?

Data Unavailable

Is Adagene Growing As A Company?

Data Unavailable

Adagene Stock Price Performance

  • Did Adagene Stock Go Up Last Month?
    Adagene share price went down by -2.39% last month
  • Did ADAG's Share Price Rise Over The Last Year?
    ADAG share price rose by 13.33% over the past 1 year

What Is Adagene 52-Week High & Low?

  • What Is Adagene’s 52-Week High Share Price?
    Adagene has traded as high as $4.38 over the past 52 weeks
  • What Is Adagene’s 52-Week Low Share Price?
    Adagene has traded as low as $1.60 over the past 52 weeks

Adagene Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adagene?

Data Unavailable

Is Adagene Cash Flow Positive?

Data Unavailable

Adagene Return On Invested Capital

Data Unavailable

Adagene Earnings Date & Stock Price

  • What Is Adagene's Stock Price Today?
    A single share of ADAG can be purchased today for 2.04
  • What Is Adagene’s Stock Symbol?
    Adagene trades on the nasdaq under the ticker symbol: ADAG
  • When Is Adagene’s Next Earnings Date?
    The next quarterly earnings date for Adagene is scheduled on March 28, 2025
  • When Is ADAG's next ex-dividend date?
    Adagene's next ex-dividend date is December 22, 2024
  • How To Buy Adagene Stock?
    You can buy Adagene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Adagene Competitors

  • Who Are Adagene's Competitors?
    Below is a list of companies who compete with Adagene or are related in some way:
    • CASI Pharmaceuticals Inc (CASI)
    • China Pharma Holding Inc (CPHI)
    • LakeShore Biopharma Co Ltd (LSB)
    • Sinovac Biotech Ltd (SVA)
    • Zai Lab Ltd (ZLAB)

Adagene Dividend Yield

Data Unavailable

Adagene Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable